SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
T/FIF Portfolio
An SI Board Since August 1998
Posts SubjectMarks Bans
1073 31 0
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
798 Do you know anything about Collateral Therapeutics (CLTX). For a third tier wiW PAUL-4/16/1999
797 <You know there has been quite a bit of press in the sector lately.> ToLLCF-4/16/1999
796 You know there has been quite a bit of press in the sector lately... things areLLCF-4/15/1999
795 You're probably right, as it's pretty low on cash, & has a long wanigel bates-4/14/1999
794 We have some spare money in "dry powder", but, while I like it at thiscaram(o)uche-4/14/1999
793 Rick, Has ABSC fallen out of its tree far enough to be included in the portfolnigel bates-4/14/1999
792 BJ, All I can offer is a slide No. 21 of the ML presentation at the SEPR web sBiomaven-4/12/1999
791 >> though you must realize that this is quite a complex issue <&lscaram(o)uche-4/12/1999
790 It is easier to respond to your query concerning sibutramine than axokine. I Biotech Jim-4/12/1999
789 If there is someone who has a comment on this it would be appreciated, it seemsLLCF-4/11/1999
788 Thanks so much for the modafinil analysis! Greatly appreciated. Anyone have aLLCF-4/11/1999
787 Thanks, BJ for the modafinil analysis. While we have you in an expansive moodBiomaven-4/11/1999
786exchange2000.comscaram(o)uche-4/11/1999
785 What do you think of Mike Murphy? Kushi Kullar-4/11/1999
784 OK David and Richard, I'll bite at a commentary on modafinil and obesity. Biotech Jim-4/11/1999
783 Richard, I'm one of those nameless masses who have you bookmarked, becauseMark Adams-4/11/1999
782 David: Saw that. One of the most intriguing posts that I've seen. Not goscaram(o)uche-4/11/1999
781 Robbins-Roth also has an irregular column in Forbes now (roughly once a month).gue-4/11/1999
780 Robbins-Roth..... a subscription is sort of pricey, but it's worth it. Mscaram(o)uche-4/11/1999
779 < They have vested interests, and they are paid to maintain them.> I coLLCF-4/11/1999
778 Rick, not being a scientist, but only a student of the scientist, I don't eLLCF-4/11/1999
777 Heated debate at the Biotech Rumor Mill over ISIP and antisense. Please conducscaram(o)uche-4/10/1999
776 Well, we shall see how easy it is to reduce the number of posts!--I have foundMike McFarland-4/10/1999
775 Since I've made an enemy of every biotech portfolio manager and analyst knoscaram(o)uche-4/10/1999
774 >> these guys are such boneheads << I want to emphasize that I havscaram(o)uche-4/10/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News